<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02267161</url>
  </required_header>
  <id_info>
    <org_study_id>ID-RCB: 2014-A00625-42</org_study_id>
    <nct_id>NCT02267161</nct_id>
  </id_info>
  <brief_title>Infants With Agenesis of the Corpus Callosum</brief_title>
  <acronym>Dacci</acronym>
  <official_title>Outcome of Infants With Prenatal Corpus Callosum Agenesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the neurological development at three years of age of
      children born after prenatal diagnosis of &quot;isolated&quot; agenesis of the corpus callosum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Agenesis of the corpus callosum is the most frequent brain malformation. This anomaly may be
      diagnosed by ultrasound screening. In half of these prenatal cases, the anomaly seems to be
      isolated. In this setting, there are no prospective data concerning the development of these
      children, preventing any clear information to be delivered to parents. Prenatal diagnostic
      centers therefore face extremely variable rates of termination of pregnancies (TOP), which
      can reach up to 80%.

      This is a multicentric prospective interventional study whose primary objective is to assess
      the neurological development at three years of age of children born after prenatal diagnosis
      of &quot;isolated&quot; agenesis of the corpus callosum.

      Evaluation at three years will include Intellectual Quotient (IQ) quantification using the
      WPPSI-III, 3rd edition of Wechsler Preschool and Primary Scale of Intelligence and evaluation
      of intra-hemispheric coordination using the Vineland adaptative behaviour scale.

      Secondary objectives will include:

        -  Circumstances leading to the prenatal diagnosis of agenesis of the corpus callosum

        -  Causes leading to termination of pregnancies

        -  Determination of criteria allowing to confirm that agenesis of the corpus callosum is
           isolated (family history, imagery, genetics)

      These results could allow to determine the optimal prenatal management of such cases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WPPSI-III (wechsler preschool and primary scale of intelligence) :evaluation of intellectual quotient ( questionnaire)</measure>
    <time_frame>3 years</time_frame>
    <description>Neurodevelopment outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vineland adaptative behaviour scales (motricity capacity) : questionnaire</measure>
    <time_frame>3 years</time_frame>
    <description>Neurodevelopment outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nepsy : developmental neuropsychological assessment (capacity of coordination)</measure>
    <time_frame>3 years</time_frame>
    <description>Neurodevelopment outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CBCL: Child Behavior Checklist (behaviour) : self administered questionnaire</measure>
    <time_frame>3 years</time_frame>
    <description>Neurodevelopment outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral abnormalities</measure>
    <time_frame>up to 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Agenesis of the Corpus Callosum</condition>
  <arm_group>
    <arm_group_label>neuropsycological tests</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Psychometric scales for infants at 3 years of age</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Psychometric scales for infants at 3 years of age</intervention_name>
    <description>WPPSI-III, VINELAND, CBCL, NEPSY</description>
    <arm_group_label>neuropsycological tests</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women from 28 weeks of gestation

          -  Complete agenesis of the corpus callosum

          -  Partial agenesis of the corpus callosum

          -  Abnormal corpus callosum (size, anatomy) As diagnosed by an expert ultrasound fetal
             brain examination.

        Exclusion Criteria:

          -  age &lt; 18 years old

          -  women who do not understand french

          -  women not covered by the French social security system

          -  refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Marie Jouannic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Marie Jouannic, MD, PhD</last_name>
    <phone>+331 44 73 52 28</phone>
    <email>jean-marie.jouannic@trs.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nelly Briand, PhD</last_name>
    <phone>+33 1 44 38 18 62</phone>
    <email>nelly.briand@nck.aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Marie Jouannic, MD, PhD</last_name>
      <phone>+331 44 73 52 28</phone>
      <email>jean-marie.jouannic@trs.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Sotiriadis A, Makrydimas G. Neurodevelopment after prenatal diagnosis of isolated agenesis of the corpus callosum: an integrative review. Am J Obstet Gynecol. 2012 Apr;206(4):337.e1-5. doi: 10.1016/j.ajog.2011.12.024. Epub 2011 Dec 27. Review.</citation>
    <PMID>22284958</PMID>
  </reference>
  <reference>
    <citation>Moutard ML, Kieffer V, Feingold J, Lewin F, Baron JM, Adamsbaum C, Gélot A, Isapof A, Kieffer F, de Villemeur TB. Isolated corpus callosum agenesis: a ten-year follow-up after prenatal diagnosis (how are the children without corpus callosum at 10 years of age?). Prenat Diagn. 2012 Mar;32(3):277-83. doi: 10.1002/pd.3824.</citation>
    <PMID>22430728</PMID>
  </reference>
  <reference>
    <citation>Moutard ML, Kieffer V, Feingold J, Kieffer F, Lewin F, Adamsbaum C, Gélot A, Campistol I Plana J, van Bogaert P, André M, Ponsot G. Agenesis of corpus callosum: prenatal diagnosis and prognosis. Childs Nerv Syst. 2003 Aug;19(7-8):471-6. Epub 2003 Jul 4.</citation>
    <PMID>12845459</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2014</study_first_submitted>
  <study_first_submitted_qc>October 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2014</study_first_posted>
  <last_update_submitted>April 13, 2018</last_update_submitted>
  <last_update_submitted_qc>April 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>agenesis</keyword>
  <keyword>corpus callosum</keyword>
  <keyword>prenatal diagnosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Agenesis of Corpus Callosum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

